
Japanese Encephalitis reduced to single digit in UP, spread of AES also down
The spread of Acute Encephalitis (AES), another form of JE, has also reduced, they added.
Officials said due to the efforts being made by the government against the communicable diseases, Japanese Encephalitis is inching closer to eradication.
For the last more than five decades, this disease was synonymous with death in Purvanchal. Every year thousands of children died prematurely.
When Chief Minister Yogi Adityanath took over in 2017, he gave the eradication of the disease the form of a mass movement. For this, a coordination committee of 17 departments was formed by keeping the Health Department as the nodal agency.
The 17 departments included Urban and rural development, panchayati raj, education department, Jal Jeevan Mission and others.
Like every year, this time under the Communicable Disease Campaign which ran from July 1 to July 31 in the state, a cleanliness campaign along with awareness was run in JE and AES-affected districts of Gorakhpur, Kushinagar, Maharajganj, Deoria, Basti, Sant Kabir Nagar, Siddharth Nagar, Azamgarh and Mau. The result is that the scope of this disease has further reduced.
According to state surveillance officer Dr Vikasendu Agarwal, this time from January till now, 137 cases of AES have been reported, but there has been no death. Last year 332 AES cases were reported. However, only 4 cases of JE have been reported this time. Last year, 18 such cases came to light.
Similarly, this time only one case of Kala Azar has been found in the state, whereas 827 cases of dengue have been detected. Last year this figure was 451. Similarly, this time 129 cases of Chikungunya have been reported, whereas last year, the figure was 128. This time 7,419 cases of malaria have been reported. Last year this figure was 3,013.
Regarding the increase in dengue cases, doctors say that it increases every third year. Therefore, there are chances of an uptick this time. Monsoon rain is also being cited as a reason behind malaria cases.
UNI MBD PRS
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
14 hours ago
- Time of India
JE death rate surges to 16% amid decline in cases
Guwahati: The death rate from Japanese Encephalitis (JE) in Assam has alarmingly risen to 16% this year, with 59 fatalities out of 354 cases, compared to last year's 7% (36 deaths out of 511 cases). This increase comes despite a declining trend in the number of cases. On Wednesday, three new JE cases were reported — two from Dhubri and one from Karbi Anglong East — but no new deaths were recorded. Medical experts attribute the spike in fatalities to inadequate prolonged treatment, although heightened awareness has helped control the number of cases. In optimal healthcare settings, the JE case fatality rate ranges from 2% to 5%. However, in endemic regions like Assam, a 25% death rate is considered average, according to health officials. "JE case fatality rates in endemic zones can reach 25% to 30%. Last year, the death rate was low relative to the number of cases, but this year, despite identifying JE cases, some patients succumbed due to deteriorating health conditions," said a senior state health department official overseeing the JE situation. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Become Fluent in Any Language Talkpal AI Undo In 2022, Assam reported 96 JE deaths, one of the highest in recent years. With July being a peak month for JE, health department sources remain hopeful that the situation will not worsen. However, patient transfers between hospitals, disrupting monitoring, may have contributed to some deaths. "Sometimes, dissatisfied attendants move patients to another hospital, leading to fatalities during transit," a source said. From Jan 1 to Aug 6, the highest number of JE deaths were reported in Nagaon and Nalbari districts, with five each, followed by four deaths each in Barpeta, Biswanath, Sonitpur, and Udalguri. Three deaths each occurred in Bajali, Bongaigaon, Darrang, Dhemaji, and Jorhat, indicating a higher death toll in lower, northern, and upper Assam. Karbi Anglong East reported the highest number of JE cases at 31, followed by 22 cases each in Golaghat and Nalbari. Lakhimpur and Nagaon each reported 20 cases. Notably, Tamulpur and Dima Hasao are the only districts among Assam's 35 that have reported no JE cases this year.


United News of India
20 hours ago
- United News of India
WHO hails Indian study on nutrition's role in TB as global guideline
New Delhi, Aug 6 (UNI) A study conducted by India that demonstrated the positive impact of nutrition on tuberculosis (TB) outcomes has drawn the attention of the World Health Organisation (WHO) which has described it 'as a global guidance on combating the world's most infectious disease.' Led by the Indian Council of Medical Research (ICMR), the study — conducted in Jharkhand — provided the first evidence that offering additional nutrition helps prevent TB cases and reduces mortality in India. 'The findings from India's RATIONS study on the impact of nutrition on TB outcomes and incidence have contributed to global guidance,' the WHO said during a three-day virtual workshop. The study, 'Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India' is published in The Lancet Global Health in 2023. The researchers of the study had provided nutritional support to a cohort with a high prevalence of severe undernutrition in the State. The results were encouraging. 'Weight gain, particularly in the first 2 months, was associated with a substantially decreased hazard of tuberculosis mortality. Nutritional support needs to be an integral component of patient-centred care to improve treatment outcomes in such settings,' said the study. Asserting the member nations to share such innovative practices, the WHO has urged the South-East Asia Region — which accounts for the highest share of TB cases and deaths globally — to also urgently scale up research and innovation to meet End TB goals. 'In our region alone, nearly 5 million people developed TB and close to 600,000 died from the disease in 2023,' said Dr. Catharina Boehme, Officer-in-Charge, WHO South-East Asia Region in a statement here. She further added, 'Achieving the ambitious targets of the WHO End TB Strategy requires collaboration to accelerate research and innovation. This includes adopting and using new tools, technologies, and drugs. Ensuring timely and equitable access to these innovations is critical to achieving impact at scale, leaving no one behind.' The WHO noted that the South-East Asia Region has made notable progress, including a rise in TB case notifications in 2023 — a sign of recovery following COVID-19-related setbacks, however, progress remains insufficient to meet End TB Strategy targets. Following the pandemic, noted the WHO, as per the statement, TB has re-emerged as the world's leading cause of death from a single infectious agent. The disease disproportionately affects the poorest and most vulnerable, deepening existing inequalities. To counter this, 'countries in the region are increasingly leveraging new approaches such as artificial intelligence for case detection, computer-aided diagnostics, digital adherence tools, and direct benefit transfers for patients to streamline social support,' the WHO said. 'Our progress is uneven. Research and innovation capacity varies across the region, and the results of these efforts are often siloed and inaccessible for collaborative use. The rise in drug-resistant TB remains very concerning,' said Boehme. UNI AJ SSP


United News of India
2 days ago
- United News of India
Supreme Court cancels bail granted to Dheeraj Wadhawan in Rs. 34,000 crore bank fraud case
New Delhi, Aug 5 (UNI) In a significant development, the Supreme Court of India today set aside the order passed by High Court of Delhi granting bail on medical grounds to accused Dheeraj Wadhawan in a case involving bank fraud to the tune of Rs. 34,000 crores. During the course of hearing the matter, the apex court constituted a board of Doctors of Sir J.J. Hospital, Mumbai to assess the medical condition of accused Dheeraj Wadhawan. The board examined the medical condition of the accused and submitted its report to Hon'ble Supreme Court. Considering the findings of the report that the accused does not require any immediate medical support/treatment, despite serious contesting by the advocates for the accused, Supreme Court set aside the order of Delhi High Court. The apex court has directed accused Dheeraj Wadhawan to surrender within two weeks. The CBI was represented by ASG S.V. Raju, in the matter. UNI ATK RN